Remternetug clinical trials
Also written LY3372993.
How each study uses remternetug is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the remternetug studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2024 (3)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 2
Eli Lilly and Company (6) · Washington University School of Medicine (2)
Studies
Open first, then newest update. How each study uses remternetug is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationRecruitingPhase 2/3Washington University School of MedicineNCT05552157Written as Remternetug (SC)
- A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationRecruitingPhase 2/3Washington University School of MedicineNCT06647498Written as Remternetug
- A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)Active, not recruitingPhase 3Eli Lilly and CompanyNCT06653153Written as Remternetug
- A Study of Remternetug (LY3372993) in Healthy Chinese ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT07346495Written as LY3372993
- A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)CompletedPhase 3Eli Lilly and CompanyNCT05463731Written as Remternetug (IV)
- A Study of Remternetug (LY3372993) in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT07056309Written as Remternetug (Test)
- A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT04451408Written as LY3372993
- A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)CompletedPhase 1Eli Lilly and CompanyNCT03720548Written as LY3372993
Codes
What other systems call remternetug · ClinicalTrials.gg INT015972
- UNII (FDA) A5HTA4J6MEREMTERNETUGOne source FDA
- NCI Thesaurus C190754RemternetugOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | A5HTA4J6ME | REMTERNETUG | One source FDA |
| NCI Thesaurus | C190754 | Remternetug | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.